BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20190483)

  • 1. Massive ascites associated with all-trans retinoic acid treatment in therapy-related acute promyelocytic leukemia.
    Suzukawa M; Nakazora T; Kawasaki Y; Tominaga T; Shinohara K
    Intern Med; 2010; 49(5):457-60. PubMed ID: 20190483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A third complete remission of acute promyelocytic leukemia achieved by administering a gradual increase of all-trans retinoic acid following massive ascites due to retinoic acid syndrome].
    Tsujioka T; Wada H; Yata K; Suemori S; Yamada O; Sugihara T
    Rinsho Ketsueki; 2003 Jul; 44(7):474-6. PubMed ID: 12931568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Treatment of Therapy-related Acute Promyelocytic Leukemia with All-trans-retinoic acid Following Epirubicin for Hepatocellular Carcinoma and Docetaxel and Pembrolizumab Therapies for Lung Carcinoma: A Triple Malignancy Case.
    Suzuki R; Kawai H; Furuya D; Akashi H; Ogawa Y; Kawada H; Ando K
    Tokai J Exp Clin Med; 2020 Jul; 45(2):92-96. PubMed ID: 32602108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypercalcemia associated with all-trans retinoic acid therapy for microgranular type acute promyelocytic leukemia].
    Hisatake J; Shimozuma J
    Rinsho Ketsueki; 2008 Jun; 49(6):408-12. PubMed ID: 18646608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful treatment of acute promyelocytic leukemia complicated by liver cirrhosis with all-trans retinoic acid and reduced-dose anthracycline chemotherapy].
    Taya Y; Mitsuki T; Kaji D; Ishiwata K; Wake A
    Rinsho Ketsueki; 2018; 59(12):2561-2566. PubMed ID: 30626789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Paralytic ileus during treatment of acute promyelocytic leukemia with all-trans retinoic acid].
    Kanisawa Y; Kawanishi N; Hisai H; Araya H; Akiyama T; Takahari D
    Rinsho Ketsueki; 2000 Aug; 41(8):687-9. PubMed ID: 11020999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [All-trans retinoic acid-induced myelomonocytoid differentiation in acute promyelocytic leukemia].
    Mori H; Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Niikura H; Omine M; Fujita K
    Rinsho Ketsueki; 1997 May; 38(5):440-4. PubMed ID: 9194390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNS relapses of acute promyelocytic leukemia after all-trans retinoic acid.
    Burry LD; Seki JT
    Ann Pharmacother; 2002 Dec; 36(12):1900-6. PubMed ID: 12452754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
    Chen SJ; Chen LJ; Zhou GB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
    Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute promyelocytic leukemia with isochromosome 17q and cryptic PML-RARA successfully treated with all-trans retinoic acid and arsenic trioxide.
    Shepshelovich D; Oniashvili N; Parnes D; Klein A; Muchtar E; Yeshaya J; Aviram A; Rabizadeh E; Raanani P
    Cancer Genet; 2015 Nov; 208(11):575-9. PubMed ID: 26471811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complete remission induced by combined treatment with all-trans retinoic acid (ATRA) and granulocyte colony-stimulating factor (G-CSF) in a patient with relapsed acute promyelocytic leukemia].
    Wakayama T; Furuya H; Takagi C; Ichiba S; Kato Y
    Rinsho Ketsueki; 1994 Nov; 35(11):1315-21. PubMed ID: 7529843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts.
    Park TS; Lee ST; Kim JS; Song J; Lee KA; Kim SJ; Seok YM; Lee HJ; Han JH; Kim JK; Lee EY; Choi JR
    Cancer Genet Cytogenet; 2009 Jan; 188(1):48-51. PubMed ID: 19061780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
    Naeem M; Harrison K; Barton K; Nand S; Alkan S
    Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic complications in acute promyelocytic leukemia during all-trans-retinoic acid therapy.
    Pogliani EM; Rossini F; Casaroli I; Maffe P; Corneo G
    Acta Haematol; 1997; 97(4):228-30. PubMed ID: 9158667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
    Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
    Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intracranial hypertension in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid].
    Tanaka T; Akifuji Y; Mori M; Ueki J; Nakamoto S
    Rinsho Ketsueki; 1997 Jan; 38(1):47-51. PubMed ID: 9028161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacology of all-trans retinoic acid (ATRA)].
    Robak T
    Acta Haematol Pol; 1995; 26(3):269-77. PubMed ID: 8525772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophagocytic syndrome associated with retinoic acid syndrome in acute promyelocytic leukemia.
    García-Suárez J; Bañas H; Krsnik I; De Miguel D; Reyes E; Burgaleta C
    Am J Hematol; 2004 Jun; 76(2):172-5. PubMed ID: 15164385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of all-trans retinoic acid for molecular relapse of acute promyelocytic leukemia during remission.
    Tamura S; Takemoto Y; Takami S; Kinoshita M; Kumano Y; Aono H; Mori M; Kakishita E
    Oncol Rep; 1999; 6(3):683-5. PubMed ID: 10203615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.